Temperature monitoring sensors for safe air travelling

Honeywell ThermoRebellion™ is a field-tested thermal imaging and artificial intelligence system to screen air travellers for elevated skin temperatures.

Honeywell, recently announced that USA has expanded its deployment of Honeywell ThermoRebellion™ temperature monitoring solution to support domestic and international passengers at Boston Logan International Airport.

“Protecting the health and safety of air travellers and our workforce is our top priority,” said David Barker, CEO of Dnata USA. “Our positive experience with the Honeywell ThermoRebellion installation at JFK International Airport convinced us to replicate the same success at Boston Logan International Airport in support of Dnata customers. With this we can deliver the highest levels of safety and efficiency for our airline partners, as well as their passengers.”

The Honeywell ThermoRebellion temperature monitoring solution can be rapidly deployed at entry points in airports, office buildings, schools, large retailers and other high-traffic locations to quickly and efficiently identify individuals exhibiting elevated skin temperature. The solution, which was introduced in the U.S. last year and Europe earlier this year, helps customers implement site monitoring protocols.

As an individual passes in front of the high-resolution, thermal imaging camera, his or her skin temperature is automatically detected within seconds and results are displayed on accompanying monitors. Those individuals who display an elevated skin temperature, based on settings established by the operator, can be guided to undergo secondary screening.

Honeywell also offers a portfolio of Healthy Buildings solutions that provide a holistic view of a building’s health based on key factors such as indoor air quality, occupant flow, personal protective equipment analytics, social distancing and sanitation efficacy.

Honeywell ThermoRebellion™ is not currently FDA 510(k) cleared or approved. The Honeywell ThermoRebellion measurement should not be solely or primarily relied upon to diagnose or exclude a diagnosis of COVID-19, or any other disease. Elevated temperature identified by the Honeywell ThermoRebellion™ system should be confirmed with secondary evaluation methods (e.g., an NCIT or clinical grade contact thermometer). Public health officials, through their experience with the Honeywell ThermoRebellion device in the particular environment of use, should determine the significance of any elevated temperature based on the skin tele-thermographic temperature measurement. The Honeywell ThermoRebellion technology should be used to measure only one subject’s temperature at a time. Visible patterns are only intended for locating the points from which to extract the thermal measurement.

For more info, visit: www.honeywell.com.